Latest market price
59.58
-5.33-8.21%
OverviewShort InterestFilings
AISVistaShares Artificial Intelligence Supercycle ETF·AMEX
59.58-8.21%
TA
Loading chart...
Screen all →
VXUS-1.53%$82.37VUG-3.00%$85.06VTV-0.38%$228.02VO-0.95%$81.46VGT-4.32%$116.96VB-1.58%$290.05VWO-1.93%$55.51VIG-0.56%$247.76
Fund Snapshot
Category—Asset TypeEquityTagsAIReturn% 1Y48.17%Total Holdings64Perf Week-0.55%
SponsorVistaSharesETF TypeTagsthematicReturn% 3Y—AUM$1.16BPerf Month-21.75%
Fund FamilyBond TypeTags—Return% 5Y—NAV/shPerf Quarter-8.70%
Index—Average MaturityTags—Return% 10Y52W High88.80 -32.91%Perf Half Y-1.97%
Index WeightingCommodity TypeTags—Return% SI52W Low33.35 78.65%Perf YTD57.74%
Active/PassiveQuant TypeTags—Flows% 1M0.00%Volatility3.40% 3.08%Perf Year45.67%
Dividend TTM—ESG TypeTags—Flows% 3M0.00%ATR (14)3.02Perf 3Y—
Dividend Ex-Date—Dividend TypeSector/ThemeFlows% YTD0.00%RSI (14)36.59Perf 5Y—
Dividend Gr. 3/5Y—Structure TypeRegionFlows% 1YBeta2.90Perf 10Y—
Expense0.75%Growth/ValueSMA20-11.10%Flows% 3YRel Volume1.65Prev Close64.91
Inverse/LeveragedMarket CapSMA50-14.25%Flows% 5YAvg Volume529.15KPrice59.58
IPO DateDec 03, 2024Option/ShortYes / YesSMA200-3.85%52W Range %47%Volume870,664Change-8.21%
Holdings Breakdown
View Holdings as
Stocks
91.5%Technology
8.3%Industrials
0.3%Consumer Defensive
Bonds, Cash & Other
0.0%Cash & Others
Assets Under Management
080.00M160.00M240.00M320.00M'25MarMayJulSepNov'26MarMayJulSep
● Assets Under Management
Latest News· Times ET
Oct-27-26
Oct-27-2608:44AM
Anthropic’s $750B Compute Ambition Puts SOXX, SMH and AI Infrastructure ETFs in FocusBenzinga
Oct-26-26
Oct-26-2610:00PM
Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercializationgurufocus.com
Oct-22-26
Oct-22-2609:00AM
DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trialgurufocus.com
Oct-12-26
Oct-12-2605:00AM
Micot Pharma Debuts MT200605 Huntington's Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseasesgurufocus.com
Sep-25-26
Sep-25-2604:14AM
The Zacks Analyst Blog Highlights CHAT, BWET, BNO, AIS, EWY and FTXLYahoo
Sep-24-26
Sep-24-2610:01AM
5 ETF Areas That Have Nearly Doubled in First Nine Months of 2026zacks.com
Sep-15-26
Sep-15-2609:38AM
The VistaShares Artificial Intelligence Supercycle® ETF (AIS) Hits $1 Billion in Assetsglobenewswire.com
Aug-31-26
Aug-31-2608:00AM
Micot Pharma Reports Positive Operating Cash Flow and Advances Late-Stage Pipeline in 1H 2026gurufocus.com
Aug-28-26
Aug-28-2605:05PM
This AI Fund Is Crushing QQQ, and Nvidia Is Barely 2% of It247wallst.com
Aug-27-26
Aug-27-2609:51AM
NVIDIA Raises the Bar on AI Growth: AI ETFs to Winzacks.com
Aug-24-26
Aug-24-2608:08AM
AIS: After A 136% Gain, The Best AI Trade Goes Beyond Chipsseekingalpha.com
Aug-18-26
Aug-18-2609:37AM
You’re Already Funding the AI Bubble — and You’ll Pay for the BustBenzinga
Aug-07-26
Aug-07-2610:00AM
Micot Pharma's MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026gurufocus.com
Aug-06-26
Aug-06-2605:14AM
Aeris Resources (ASX:AIS) Following FY27 Guidance Faces Fresh Questions On ValuationYahoo
Aug-04-26
Aug-04-2605:54AM
AIS: A Primer On The VistaShares Artificial Intelligence Supercycle ETFSeekingAlpha
Fund

This actively managed exchange-traded fund (ETF) is designed to achieve its investment objective by strategically allocating capital to a diversified portfolio of artificial intelligence (AI) companies across the globe. The sub-adviser's strategy is to manage the fund's assets in pursuit of returns that mirror those of the BITA VistaShares Artificial Intelligence Supercycle Index. Under typical market conditions, the fund commits a minimum of 80% of its net assets, including any funds borrowed for investment, to AI-focused enterprises.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR